alt Hacker NewsIt also seems to be a financial problem of getting VC funds to run trials to appease regulators. Even if you’ve already seen results in a lab or other country.
It also seems to be a financial problem of getting VC funds to run trials to appease regulators. Even if you’ve already seen results in a lab or other country.
We could have an alternative system where VC don’t need to appease regulators but must place X billion in escrow for compensation of any harm the medicine does to customers.
Regulator is not only there to protect the public, it also protects VC from responsibility